BriaCell Therapeutics Corp. (BCT.TO)
5.14
+0.32
(+6.64%)
CAD |
TSX |
Aug 25, 16:00
BriaCell Therapeutics Debt to Equity Ratio : 0.00 for April 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| April 30, 2026 | 0.00 |
| January 31, 2026 | 0.00 |
| October 31, 2025 | 0.00 |
| July 31, 2025 | 0.00 |
| April 30, 2025 | 0.00 |
| January 31, 2025 | 0.00 |
| October 31, 2024 | 0.00 |
| July 31, 2024 | 0.00 |
| April 30, 2024 | 0.00 |
| January 31, 2024 | 0.00 |
| October 31, 2023 | 0.00 |
| July 31, 2023 | 0.00 |
| April 30, 2023 | 0.00 |
| January 31, 2023 | 0.00 |
| October 31, 2022 | 0.00 |
| April 30, 2022 | 0.00 |
| January 31, 2022 | 0.00 |
| October 31, 2021 | 0.00 |
| April 30, 2021 | 0.00 |
| January 31, 2021 | -0.1092 |
| October 31, 2020 | -0.0768 |
| July 31, 2020 | -0.0694 |
| April 30, 2020 | -0.0778 |
| January 31, 2020 | -0.0666 |
| October 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| July 31, 2019 | -0.4683 |
| April 30, 2019 | 0.484 |
| January 31, 2019 | -0.8128 |
| October 31, 2018 | 2.282 |
| July 31, 2018 | 1.186 |
| April 30, 2018 | 0.4172 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.00 |
| April 30, 2017 | 0.00 |
| January 31, 2017 | 0.00 |
| October 31, 2016 | 0.00 |
| July 31, 2016 | 0.00 |
| April 30, 2016 | 0.00 |
| January 31, 2016 | 0.00 |
| October 31, 2015 | 0.00 |
| July 31, 2015 | 0.00 |
| April 30, 2015 | 0.00 |
| January 31, 2015 | 0.00 |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 0.00 |
| April 30, 2014 | 0.00 |
| January 31, 2014 | 0.00 |
| October 31, 2013 | 0.00 |
| July 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Kane Biotech, Inc. | -1.352 |
| Quest PharmaTech, Inc. | 0.0378 |
| Vaxil Bio Ltd. | 0.00 |
| Waverley Pharma, Inc. | -1.299 |
| Goldcoast Resource Corp. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 36.85M |
| Total Liabilities (Quarterly) | 4.985M |
| Shareholders Equity (Quarterly) | 32.75M |
| Current Ratio | 7.072 |